Drug
Dextromethorphan
Dextromethorphan: highest development phase Post-Market, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Dextromethorphan NCT01257542 | Post-Market | Common Cold |
Latest
No recent events.
Follow Dextromethorphan on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.